# EDGAR Filing Document

**Accession Number:** 0001131399
**File Stem:** 0001654954-25-012745
**Filing Date:** 2025-11
**Character Count:** 3486
**Document Hash:** 97ef632a3f516a0f43e46660b9110650
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-25-012745.hdr.sgml**: 20251110

**ACCESSION NUMBER**: 0001654954-25-012745

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251110

**FILED AS OF DATE**: 20251110

**DATE AS OF CHANGE**: 20251110

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GSK plc
- **CENTRAL INDEX KEY:** 0001131399
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15170
- **FILM NUMBER:** 251465027

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 79 NEW OXFORD STREET
- **CITY:** LONDON
- **PROVINCE COUNTRY:** X0
- **BUSINESS PHONE:** 44 20 8047 5000

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 79 NEW OXFORD STREET
- **CITY:** LONDON
- **PROVINCE COUNTRY:** X0

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GSK PLC
- **DATE OF NAME CHANGE:** 20220516

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GLAXOSMITHKLINE PLC
- **DATE OF NAME CHANGE:** 20010105

**UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

 **Washington, D.C. 20549**

 **Form 6-K**

 **REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16**

 **UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of November 2025

Commission File Number 001-15170

 **GSK plc**

(Translation of registrant's name into English)

 **79 New Oxford Street, London, WC1A 1DG**

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

 **GSK plc**

 **GSK publishes provisional dividend dates** 

GSK announces the following dividend dates for 2026:

These dates are indicative and may be subject to change.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Results** | **Announcement date** | **Ordinary Shares Ex-dividend date** | **American Depositary Shares Ex-dividend date** | **Record date** | **Last date for DRIP elections** | <br>**Payable** <br>|
| **Q1 2026** | Wednesday 29 April 2026 | <br> Thursday 14 May 2026 <br>| Friday 15 May 2026 | Friday 15 May 2026 | Thursday 18 June 2026 | Thursday 9 July 2026 |
| **Q2 2026** | Wednesday 29 July 2026 | Thursday 13 August 2026 | <br> Friday 14 August 2026 <br>| Friday 14 August 2026 | Thursday 17 September 2026 | Thursday 8 October 2026 |
| **Q3 2026** | <br> Wednesday 28 October 2026<br>| Thursday 12 November 2026 | Friday 13 November 2026 | Friday 13 November 2026 | Monday 14 December 2026 | Thursday 7 January 2027 |
| **Q4 2026** | <br> Wednesday 3 February 2027 <br>| Thursday 18 February 2027 | Friday 19 February 2027 | Friday 19 February 2027 | Tuesday 16 March 2027 | Thursday 8 April 2027 |

---

 **V A Whyte**

 **Company Secretary**

10 November 2025

 **SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

---

| | |
|:---|:---|
|  | **GSK plc** |
|  | (Registrant) |
| Date: November 10, 2025 |  |
|  | By:/s/ VICTORIA WHYTE<br> -------------------------- |
|  | Victoria Whyte |
|  | Authorised Signatory for and on |
|  | behalf of GSK plc |

---